New restrictions for cosmetics in the UK
In April, the UK Government announced several changes to the UK Cosmetics Regulation – some…
Digital labels to become reality in the United Kingdom
In January 2024, the United Kingdom announced further measures to ease regulatory obligations for companies.…
MHRA Policy Paper on Medical Technology strategy: a future MedTech landscape for the UK medical sector
Medical technology, also called “MedTech", is a vital part of the healthcare system. It includes…
UK Recognises extended CE Certificates
The UK Government has taken steps towards recognizing extended CE Certificates in light of the…
Approved Bodies for medical devices: UK improving conformity assessment capacity in a post-Brexit landscape
Brexit and the separation of the United Kingdom from the EU have significantly affected a…
Use of CE marking in the United Kingdom: new extensions for manufacturers
The CE marking proves that goods on the EU market meet the applicable regulatory requirements.…
First UK Approved Body since Brexit to be designated by the MHRA
One more step towards a strong UKCA regulatory framework for Medical After the withdrawal of…
New MHRA guidance on software and AI as a medical device change programme
Software, Artificial Intelligence (AI) included, plays an increasingly important and crucial role in the health…
A quick dive into GMDN and UDI codes
Global Medical Devices Nomenclature (GMDN) is an integral part of the MHRA MD and IVD…
OPSS extends transitional labelling provisions for cosmetics to 2025
On September 5, 2022, the Office for Product Safety and Standards (OPSS) published a new…